These are the supported studies so far:
Dr. Almaz Sharman
April 9th, 2018 to August 20th, 2019
* The study was initiated by Professor Riccardo Polosa. PMI consented to change principal investigator on the 31st of March 2018 and the necessary approvals were obtained on the 30th of July 2018.
Reduced Risk Products (“RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.